Info
Daniel Griffin provides his weekly clinical report on COVID-19, including new post-exposure guidelines from CDC, clinical trials of Remdesivir and convalescent plasma, FDA EUA for baricitinib and Regeneron’s monoclonal antibody and more.
hace 5 meses
#baricitinib, #clinicalreport, #covid19, #danielgriffin, #monoclonalantibody, #pandemic, #remdesivir, #sarscov2, #viral, #virology, #virus, #viruses
